000			05141cam a2200469Ii 4500
988			_aSpringer_Medicine_2017
999			_c96221 _d96221 _x1
001			96221
003			ES-MaUEC
005			20230102112744.0
006			m o d
007			cr cnu|||unuuu
008			170620t20172017sz a ob 001 0 eng d
020			_a3319564242 _q(electronic bk.)
020			_a9783319564241 _q(electronic bk.)
020			_z3319564234
020			_z9783319564234
040			_aN$T _cN$T _dN$T _dOCLCO _dGW5XE _dEBLCP _dOCLCF _dUAB _dYDX _dOCLCO _dAZU _dUPM _dIOG _dOCLCO _dKOS _dOCLCO _dMERER _dESU _dOCLCQ _dCOO _dOCLCQ _dOCLCO _dOCLCA _dMERUC _dOCLCO _dES-MaUEC _bspa
050		4	_aRC268.48 _b2017 EB
245	0	0	_aPET/CT in cancer of unknown primary _cNagabhushan Seshadri, Chinnamani Eswar, editors.
264		1	_aCham, Switzerland _bSpringer _c[2017]
264		4	_c2017
300			_a1 recurso en línea _bilustraciones (algunas a color)
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF
490	0		_aClinicians' guides to radionuclide hybrid imaging. PET/CT _x2367-2439
500			_aSpringerLink
504			_aIncluye referencias bibliográficas e índice
505	0		_aForeword; Preface; Acknowledgements; Contents; Contributors; 1: Cancer of Unknown Primary (CUP); 1.1 Introduction; 1.2 Epidemiology; 1.3 Clinical Presentation/Signs and Symptoms; 1.4 Diagnosis and Staging Procedures/Investigations; 1.5 Prognosis; References; 2: An Overview of the Pathology of Cancer of Unknown Primary; 2.1 Introduction; 2.2 Immunohistochemistry; 2.3 Molecular Diagnosis; 2.4 Subsets; References; 3: An Overview of the Management of Cancer of Unknown Primary; 3.1 Introduction; 3.2 Surgical; 3.3 Chemotherapy; 3.4 Radiotherapy; 3.5 Supportive Therapies.
505	8		_a3.6 Management of CUP Patients Who Do Not Fall into Any Specific SubsetReferences; 4: Radiological Imaging in Cancer of Unknown Primary; 4.1 Introduction; 4.2 Ultrasound; 4.3 Computed Tomography (CT); 4.4 MRI; 4.5 Radionuclide Bone Scan; 4.6 Limitations of Anatomical Imaging; 4.7 Terminology; 4.8 Multimodality Imaging and Multidisciplinary Team (MDT) Approach; 4.9 Role of Imaging in Investigations and Management; 4.10 Goals of a Standard CUP Workup; 4.11 Biopsy and Histology: Important Considerations; 4.12 Pearls and Pitfalls; References.
505	8		_a5: 18F-FDG and Non-FDG PET Radiopharmaceuticals5.1 Introduction; 5.2 PET Radiopharmaceuticals; 5.2.1 18F-FDG; 5.2.2 Non-FDG Radiopharmaceuticals; References; 6: Cancer of Unknown Primary: Role of FDG PET/CT; 6.1 Introduction; 6.2 Evidence for the Use of PET/CT in CUP; 6.3 PET/CT in Response Assessment; 6.4 PET/CT in Radiotherapy Planning; 6.5 Stand-Alone PET Versus Combined PET/CT; 6.6 PET/CT Protocols; 6.7 Limitations; 6.7.1 False Positives; 6.7.2 False Negatives; 6.8 Management Impact and Cost-Effectiveness; 6.9 Future Directions; 6.10 Recommendations; References.
505	8		_a7.15 Case 157.15.1 Clinical Details; Index.
505	8		_a7: Pictorial Atlas: Cancer of Unknown Primary7.1 Case 1; 7.1.1 Clinical Details; 7.2 Case 2; 7.2.1 Clinical Details; 7.3 Case 3; 7.3.1 Clinical Details; 7.4 Case 4; 7.4.1 Clinical Details; 7.5 Case 5; 7.5.1 Clinical Details; 7.6 Case 6; 7.6.1 Clinical Details; 7.7 Case 7; 7.7.1 Clinical Details; 7.8 Case 8; 7.8.1 Clinical Details; 7.9 Case 9; 7.9.1 Clinical Details; 7.10 Case 10; 7.10.1 Clinical Details; 7.11 Case 11; 7.11.1 Clinical Details; 7.12 Case 12; 7.12.1 Clinical Details; 7.13 Case 13; 7.13.1 Clinical Details; 7.14 Case 14; 7.14.1 Clinical Details.
520	3		_aThis pocket book offers a rapid and concise overview of the utility of PET/CT in the management of patients with cancer of unknown primary (CUP). Readers will gain an appreciation of the unique information provided by PET/CT on the molecular and metabolic changes associated with CUP, which can occur in the absence of corresponding anatomical alterations. Characteristic imaging appearances are documented with the aid of a series of teaching cases that serve to illustrate the potential improvements in patient management that may be achieved through early use of PET/CT in the diagnostic pathway. In addition, the relation of the clinical and pathological background to imaging is explained. The book is published within the Springer series Clinicians' Guides to Radionuclide Hybrid Imaging (compiled under the auspices of the British Nuclear Medicine Society) and will be an excellent asset for all clinicians, nuclear medicine physicians, radiologists, radiographers, and nurses who routinely work in multidisciplinary teams involved in the management of these patients.
650		7	_aEtiología médica _2embne _0(OCoLC)fst01200399 _9140556
700	1		_aEswar, Chinnamani, _eeditor literario
700	1		_aSeshadri, Nagabhushan, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-56424-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI